Relay Medical Joint Venture Secures Over $500,000 In Initial Contracts

Relay Medical (CSE: RELA) has seen its joint venture, Fionet Rapid Response Group, acquire contracts in excess of $500,000 in initial contracts. In connection with the announcement, the company also provided a corporate update on several facets of its COVID-19 focused operation.

First and foremost, the initial contract acquired by the firm appears to be in connection with an alliance formed with South Korean rapid diagnostic test (RDT) maker IVD Lab Co. The company has entered an arrangement to bring a new rapid diagnostic test to market that is designed to distinguish between those of whom with COVID-19 are at great risk of becoming critically ill, and those of whom can recover at home.

Testing and validation of this new rapid detection test, which was partially funded by the National Research Council Canada, is currently in process at the University Health Network in Toronto. The test is designed to ease the burden on hospitals, whom are currently near capacity across the US with rising infection rates, by assisting in keeping hospital beds for those that are most in need.

Outside of this development, the company has also seen the Fionet device implemented in ten primary healthcare facilities within Kenya. The device is currently in use for a number of administrative functions, as well as for COVID-19 screening. Negotiations are currently said to be underway with additional healthcare organizations globally, where it will be deployed to support rapid testing programs.

The company is also in the process of configuring some of the most widely used rapid diagnostic tests on the market to work with that of the Fionet device. Rapid tests from manufacturers including Abbott, Roche, and Proprietary Innovation Labs have been acquired for this purpose, with the combined manufacturing capacity of these tests to exceed 145 million units a month, making them some of the most commonly used rapid tests for COVID-19.

Finally, the first production run of the joint ventures COVID-19 mobile testing devices have been received from the contract manufacturer, with additional devices expected to be received within the next two weeks. The initial devices are to be used for onboarding of rapid diagnostic tests, supporting initial pilots of the devices, and for verification activities.

Relay Medical Corp last traded at $0.23 on the CSE.


FULL DISCLOSURE: Relay Medical Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Relay Medical Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

Antimony Resources Drills 5.27% Sb Over 4.95 Metres In Latest Results

Nord Precious Metals Identifies 29 Veins At Castle East Following 3D Modeling

Related News

Deutsche Bank Proposes 5% ‘Privilege’ Tax on Those Choosing to Work From Home

The coronavirus pandemic has caused significant shifts in the typical office environment, as many employees...

Saturday, November 14, 2020, 04:03:00 PM

Demand for US Oil Could Collapse Once Again as Threat of Second Coronavirus Wave Becomes Imminent

The demand for US oil hit a disastrous low during the onset of the coronavirus...

Sunday, June 28, 2020, 12:39:00 PM

US Treasury Set to Borrow Record $2.99 Trillion in Second Quarter

As the US economy is in the middle of fighting its invisible war against the...

Tuesday, May 5, 2020, 01:22:00 PM

Where’s The Beef? Meat Processors Hammered By Coronavirus

It appears that the forewarning offered previously by the United Nations in regards to food...

Wednesday, April 15, 2020, 02:35:37 PM

‘Defensive’ ETF Inflows Soar as Wall Street’s Worried Economic Outlook Intensifies

The resurgence of Covid-19 cases across the US, coupled with the rising threat of inflationary...

Wednesday, August 18, 2021, 10:37:00 AM